National Asset Management, Inc. Novan, Inc. Transaction History

National Asset Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	BUY	$0.41 - $1.4 $2,419 - $8,260	5,900 Added 3.16%	192,900 $82,000
Q1 2023 May 17, 2023	BUY	$1.05 - $2.04 $33,600 - $65,280	32,000 Added 20.65%	187,000 $243,000
Q4 2022 Feb 21, 2023	BUY	$0.82 - $1.48 $55,104 - $99,456	67,200 Added 76.54%	155,000 $226,000
Q3 2022 Nov 14, 2022	BUY	$1.76 - $3.03 $154,528 - $266,034	87,800 New	87,800 $165,000

Ticker NOVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,281,600
Market Cap $638K
Description
Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-sp...

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on National Asset Management, Inc. with notifications on news.